An open-label phase 2 study of the efficacy and safety of glufosfamide in previously treated advanced soft tissue sarcoma.

Trial Profile

An open-label phase 2 study of the efficacy and safety of glufosfamide in previously treated advanced soft tissue sarcoma.

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2015

At a glance

  • Drugs Glufosfamide (Primary)
  • Indications Soft tissue sarcoma
  • Focus Therapeutic Use
  • Sponsors Eleison Pharmaceuticals
  • Most Recent Events

    • 12 May 2009 Actual end date (1 Oct 2008) added as reported by ClinicalTrials.gov.
    • 18 Jan 2008 Results have been reported in a Threshold Pharmaceuticals media release.
    • 05 Dec 2007 Status changed from recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top